EFFECT OF COLESTIPOL HYDROCHLORIDE ON THE BIOAVAILABILITY AND PHARMACOKINETICS OF CLOFIBRATE

被引：11

作者：

DESANTE, KA

DISANTO, AR

ALBERT, KS

WEBER, DJ

WELCH, RD

VECCHIO, TJ

机构：

[1] Upjohn Company, Kalamazoo, Michigan

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1979年 / 19卷 / 11-1期

关键词：

D O I：

10.1002/j.1552-4604.1979.tb01642.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：721 / 725

页数：5

共 7 条

[1] EFFECTS OF COLESTIPOL RESIN AND OF COLESTIPOL PLUS CLOFIBRATE ON TURNOVER OF PLASMA CHOLESTEROL IN MAN [J].

GOODMAN, DS ;

NOBLE, RP ;

DELL, RB .

JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (10) :2646-2655

[2]

GRUNDY SM, 1977, J LAB CLIN MED, V89, P354

[3]

HOUIN G, 1975, EUR J CLIN PHARMACOL, V8, P433, DOI 10.1007/BF00562318

[4]

METZLER CM, USERS MANUAL NONLIN

[5] CONTROLLED CLINICAL TRIAL OF A NEW BILE ACID SEQUESTERING RESIN, COLESTIPOL, IN TREATMENT OF HYPERCHOLESTEROLEMIA [J].

MILLER, NE ;

CLIFTONB.P ;

NESTEL, PJ ;

WHYTE, HM .

MEDICAL JOURNAL OF AUSTRALIA, 1973, 1 (25) :1223-1227

[6] CLOFIBRATE-INDUCED LOW-DENSITY LIPOPROTEIN ELEVATION - THERAPEUTIC IMPLICATIONS AND TREATMENT BY COLESTIPOL RESIN [J].

ROSE, HG ;

HAFT, GK ;

JULIANO, J .

ATHEROSCLEROSIS, 1976, 23 (03) :413-427

[7]

STEIN EA, 1975, S AFR MED J, V49, P1252

← 1 →